Patent classifications
C07D487/22
Corrole-based frameworks and methods of use thereof
Described herein are corrole-based frameworks and methods for making the same. The corrole-based frameworks have unique structural and physical properties, which lends them to be versatile in a number of different applications and uses such as in gas storage/separation, proton conduction, biomedicine, sensing, and catalysis. In one aspect, the corrole-based frameworks are organic frameworks. In other aspects, the corrole-based frameworks are metal-organic frameworks.
TEXAPHYRIN-PT(IV) CONJUGATES AND COMPOSITIONS FOR USE IN OVERCOMING PLATINUM RESISTANCE
The present disclosure relates platinum(IV) and texaphyrin linked conjugates and compositions comprising a texaphyrin and a platinum(IV) agent. The present disclosure also provides pharmaceutical compositions of the conjugates and compositions. Also, provided herein are methods of using the instant compounds in the treatment of cancer such as a platinum resistant cancer.
TEXAPHYRIN-PT(IV) CONJUGATES AND COMPOSITIONS FOR USE IN OVERCOMING PLATINUM RESISTANCE
The present disclosure relates platinum(IV) and texaphyrin linked conjugates and compositions comprising a texaphyrin and a platinum(IV) agent. The present disclosure also provides pharmaceutical compositions of the conjugates and compositions. Also, provided herein are methods of using the instant compounds in the treatment of cancer such as a platinum resistant cancer.
SUBSTITUTED MACROCYCLIC INDOLE DERIVATIVES
- Kai Thede ,
- Anne Mengel ,
- Clara Christ ,
- Joachim Kuhnke ,
- Sarah Anna Liesa Johannes ,
- Philipp Buchgraber ,
- Ulrich Klar ,
- Ulrike Rauh ,
- Stefan Kaulfuss ,
- Amaury Ernesto Fernandez-Montalvan ,
- Nicolas Werbeck ,
- Ursula Moenning ,
- Katrin Nowak-Reppel ,
- Sven Wittrock ,
- David McKinney ,
- Michael H. Serrano-Wu ,
- Chris Lemke ,
- Mark Fitzgerald ,
- Christopher Nasveschuk ,
- Kiel Lazarski ,
- Steven James Ferrara ,
- Laura Furst ,
- Guo Wei ,
- Patrick Ryan McCarren ,
- Rebecca Ann Harvey
The present invention relates to substituted macrocyclic indole derivatives of general formula (I):
##STR00001##
in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, A and L are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, as a sole agent or in combination with other active ingredients.
SUBSTITUTED MACROCYCLIC INDOLE DERIVATIVES
- Kai Thede ,
- Anne Mengel ,
- Clara Christ ,
- Joachim Kuhnke ,
- Sarah Anna Liesa Johannes ,
- Philipp Buchgraber ,
- Ulrich Klar ,
- Ulrike Rauh ,
- Stefan Kaulfuss ,
- Amaury Ernesto Fernandez-Montalvan ,
- Nicolas Werbeck ,
- Ursula Moenning ,
- Katrin Nowak-Reppel ,
- Sven Wittrock ,
- David McKinney ,
- Michael H. Serrano-Wu ,
- Chris Lemke ,
- Mark Fitzgerald ,
- Christopher Nasveschuk ,
- Kiel Lazarski ,
- Steven James Ferrara ,
- Laura Furst ,
- Guo Wei ,
- Patrick Ryan McCarren ,
- Rebecca Ann Harvey
The present invention relates to substituted macrocyclic indole derivatives of general formula (I):
##STR00001##
in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, A and L are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, as a sole agent or in combination with other active ingredients.
HOST MATERIAL, COMPOSITION, AND ORGANIC ELECTROLUMINESCENT ELEMENT
To improve the emission efficiency, the driving voltage and the lifetime of an organic light-emitting device using a delayed fluorescent material. A host material for a delayed fluorescent material, containing a compound represented by the following general formula: R.sup.1 to R.sup.5 each are a substituent not containing a cyano group. n1 to n5 each are 0 to 4, Ar is a monocyclic arylene group or a monocyclic heteroarylene group.
##STR00001##
Photodynamic cationic porphyrin composites
A photodynamic composite including a porphyrin having four quaternized nitrogens, wherein the porphyrin is covalently bonded to a polymer containing reactive amines covalently bonded to a solid-state support is claimed. A method for sanitizing contaminated water is claimed including exposing the contaminated water to the photodynamic composite, in the presence of light and oxygen, wherein, a sufficient quantity of singlet oxygen and super oxide anions is provided by the chemical reaction of the light and the photosensitizer to destroy the pollutants or pathogens present in the contaminated water and to oxidize organic contaminants into carbon dioxide and water; thereby rendering the water potable.
Photodynamic cationic porphyrin composites
A photodynamic composite including a porphyrin having four quaternized nitrogens, wherein the porphyrin is covalently bonded to a polymer containing reactive amines covalently bonded to a solid-state support is claimed. A method for sanitizing contaminated water is claimed including exposing the contaminated water to the photodynamic composite, in the presence of light and oxygen, wherein, a sufficient quantity of singlet oxygen and super oxide anions is provided by the chemical reaction of the light and the photosensitizer to destroy the pollutants or pathogens present in the contaminated water and to oxidize organic contaminants into carbon dioxide and water; thereby rendering the water potable.
Heterocyclic Amides Useful as Protein Modulators
Disclosed are compounds having the formula:
##STR00001## wherein q, r, s, A, B, C, R.sup.A1, R.sup.A2, R.sup.B1, R.sup.B2, R.sup.C1, R.sup.C2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.14, R.sup.15, R.sup.16, and R.sup.17, are as defined herein, or a tautomer thereof, or a salt, particularly a pharmaceutically acceptable salt, thereof.
Heterocyclic Amides Useful as Protein Modulators
Disclosed are compounds having the formula:
##STR00001## wherein q, r, s, A, B, C, R.sup.A1, R.sup.A2, R.sup.B1, R.sup.B2, R.sup.C1, R.sup.C2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.14, R.sup.15, R.sup.16, and R.sup.17, are as defined herein, or a tautomer thereof, or a salt, particularly a pharmaceutically acceptable salt, thereof.